chrisvoncsefalvay/vaers-outcomes huggingface dataset:
According to patient the giving of the shot was uneventful, however as time goes by, his arm is sore and now radiating to his elbow. He got his PNEUMOVAX 23 on 05/04/2018.
pt recvd vax 1130AM 28APR93 about 10PM on 28APR93 pt began scratching both ears; slept OK that noc & woke in AM w/rash on rt arm; rash spread to abdo back & arm; MD dx'd allergic reaction;
Was on restraints 2 days after vaccination; She was talking all over the place; This spontaneous case was reported by a consumer and describes the occurrence of SOLILOQUY (She was talking all over the place) and PATIENT RESTRAINT (Was on restraints 2 days after vaccination) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Behaviour disorder.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2021, the patient experienced SOLILOQUY (She was talking all over the place). On an unknown date, the patient experienced PATIENT RESTRAINT (Was on restraints 2 days after vaccination). At the time of the report, SOLILOQUY (She was talking all over the place) and PATIENT RESTRAINT (Was on restraints 2 days after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.  Patient had mentioned about treatment medication as Zyprexa but she refused to take, however, she was given 2 injections in her legs, which she does not know what it was.  Patient had reported that 2 days after vaccination she was on restraints at a behavioral health facility, and already went to court. The facility made her to get the vaccine. She was calling today to say that the Facility violated her rights.
Pt c/o itching at sight of injection. Site of MMR swollen and erythematous. Benadryl 50mg 1m to left deltoid given.
Pt exp a local react which included swelling of entire arm; 48 hrs p/immun pt was taken to ER treated w/ATB & warm compresses;
Rash on the chest, neck and upper back. Rash turned bright red, then after steroids, lessened but stayed in ?splotches?. Rash was itchy at times. Felt body aches and slight chills (temperature always below 98.6 though).   Began 50mg oral prednisone on 3/6. On 3/7, rash worsened and an urgent care facility gave me a 10mg shot of dexamethesone which helped immediately.   Dermatologist recommended antihistamine course beginning 3/9.
The patient reported that she has red, warm, bumpy with a dry center at the injection site. She visited her doctor and was diagnosed with cellulites. She reported that, the doctor suspected it may be due to contaminated needle.  The doctore prescribed Cephalexin 500mg , 1 capsule q6h for 10 days.  She just took the first dose and  no sign of improvement yet.
Received vaccine 7/2/98. Diagnosed with chickenpox 12/11/02.
Patient reported having nausea and vomiting approximately 8 hours after the vaccination. The patient reported having a high fever for 24 hours post-vaccination, and a mild fever for 3 days after. The patient reported having a red swollen arm with a lump about the size of a golf ball.
Urticaria that started approximately 5 hours post vaccination. Pt stated that he started to feel itchy and when he got home he noticed he had hives all over his body. Patient came into Urgent Care and was given 50mg of benedryl which resolved the hives
70-year-old male with history of CAD, afib, 3v CABG admitted with symptoms of diaphoresis and chest pain/palpitations. In ED, symptoms improved. Troponins elevated. COVID-19 testing positive. Patient noted to be tachycardic; therefore treated with IV diltiazem for rate control and initiated IV heparin per protocol. ECG for atrial fibrillation with RVR. Educated his son on home care and services available. His son provided choice; patient did not have any preference. Agreeable to services.
Initially very mild muscle aches and fatigue. 3 to 4 days later there was weight gain of 3 pounds and edema most obvious to the upper eyelids. This worsened with itching and pain to eyes. Additionally I had difficulty focusing my mind and a general feeling of being ?unwell?.  Benadryl 60 mg reduced the eye discomfort.  Contacted providers? office, but have not heard back.
Headache began at 6:30 PM, then he became nauseated and ran a slight fever.  He vomited between 1:30 AM and 5:30 AM and had mild diarrhea.
Patient had a reaction to the vaccination resulting in a 7X5 cm red area around the sithe of injection. Was also vesicular appearing (blisters). Patient was also unsure if he had the chickenpocks before durring child hood.
Redness at site of smallpox vax. (Erythema, edema, chemical reaction)
Describes that in September (no exact date specified) she begin to experience increased muscle and joint pain and also hair loss. She has not seen a physician.
BUD Date 04/07/2022 administered 04/11/2022. Pfizer could not provide stability data beyond 04/09/2022 and recommended an additional booster administered 05/10/2022
PATIENT NOTICED BODY ACHES THEN PROGRESSED TO CHILLS AND FEVER OF 101, TESTED NEGATIVE FOR FLU 11/11/2013, TREATED WITH TYLENOL AND IBU AS NEEDED.
Red spots all over my body, arms, legs, stomach, back,  just a few the first week after, but has continued with more and more each week. 6 weeks after and I'm covered with red spots, and yes they itch as well, all over.
COVID-19 Breakthrough. I noticed a slightly sore throat the evening before testing positive. The next morning it was considerably much more sore. My voice was pretty much gone. I was also feverish. I also had body aches and fatigue. After the initial first days the congestion and cough lingered. The cough went away within the last 4-5 days. I have recovered but my tongue feels like it has been burned and hasn't returned to normal.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of GARDASIL lot # K005881, K006960 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 concerning an adult patient of an unknown age and gender who on 06-MAY-2015 was vaccinated with a dose of GARDASIL (manufacturer unknown) (lot # K006960) (dose and route not reported) that underwent a temperature excursion during an unknown amount of hours. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
COVID-19 / Tested positive three days after his son tested positive.; tightness in his chest; Appetite dropped; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (tightness in his chest), DECREASED APPETITE (Appetite dropped) and COVID-19 (COVID-19 / Tested positive three days after his son tested positive.) in a 70-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication.    Concurrent medical conditions included Prostate cancer (Treatment with radiation.), Blood pressure high, Diabetes and Hypercholesteremia. Concomitant products included SIMVASTATIN for Hypercholesteremia.   On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (unknown route) 1 dosage form. In September 2022, the patient experienced CHEST DISCOMFORT (tightness in his chest) and DECREASED APPETITE (Appetite dropped). On 27-Sep-2022, the patient experienced COVID-19 (COVID-19 / Tested positive three days after his son tested positive.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) (oral) from 28-Sep-2022 to 02-Oct-2022 for COVID-19 treatment, at a dose of 3 in morning and 3 at night for 5 days. On 03-Oct-2022, COVID-19 (COVID-19 / Tested positive three days after his son tested positive.) had resolved. At the time of the report, CHEST DISCOMFORT (tightness in his chest) and DECREASED APPETITE (Appetite dropped) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2022, Weight: Weight has dropped from 160 bs. On 27-Sep-2022, SARS-CoV-2 test: (Positive) Positive. On 28-Sep-2022, Body temperature: 101.7 and 102. On 03-Oct-2022, SARS-CoV-2 test: (Negative) Negative. In October 2022, Body temperature: 69.9. On an unknown date, Body temperature: 97.8, 97.0, 97.7 and 97.1.         Concomitant products were not reported.    It was reported that patient was more susceptible to colds and the Flu.  It was reported that patient received dose 1 on 25-Feb-2021, dose 2 on 25-Mar-2021, dose 3 on 04-Nov-2021, dose 4 on 28-May-2022. Also received the flu shot the same day as the Moderna Covid-19 Booster Vaccine in Sep2022. Patient had ill effects. patient had raw throat and tightness in chest. Fever went on, scratchy throat came within a day. Sore throat started up one or two days after being diagnosed. All subsided after that.   Did the self home test for Covid-19 on Tuesday, 27Sep2022 at midnight and following day got Paxlovid and started it that evening on the 28Sep2022. Patient had to track his blood pressure and blood sugar too.
This spontaneous report as received from a health department nurse refers to an unknown number of patients of unknown ages and genders. On unknown dates the patients were vaccinated with VARIVAX (Merck) injection which underwent a supported temperature excursion, but was outside the recommended temperature provided in the prescribing information, intramuscular (lot #, expiry date and dose unknown). No adverse effects reported. Follow up information has been received on 02-APR-2014. A phone call was placed to Registered Nurse. The Program Manager stated that nurse was unavailable at that time, but the VARIVAX (Merck) underwent a supported temperature excursion. On 10-JUL-2013, lot number: J001647, expiration date 11-FEB-2015-170 doses shipped and 10 doses were in the freezer at the time of discovery. Patient identifiers were not available at this time. No further information is available at this time. This is one of several reports from the same source. Additional information has been requested.
I received PPV shot on Monday 10-22-07. Swelling to area on arm, redness, sore. Went back to doctor on 10-23-07 and now being treated for cellulitis with 875 mil amoxy. Follow up on 10-26-07.
Swollen arm size of small apple, deep, deep intense pain.   As of today 7/28/12, seven weeks later, swelling has subsided but pain has spread to both arms and joints all over body, taking many strong pain pills;  oxycodone with Acetaminophen.
Patient received vaccine on 06/10/08 - Returned to office with fever 100deg, restless at night and extreme irritability and local reaction 4.5x6.5cm site of injection redness.
Developed a large, itchy rash approximately 1and1/2 inch below the injection site 4 days after injection.  Applied 1% cortisone ointment to site for 2 days.  Symptoms subsided.
pt exp feeling of heat during drive home followed by tightening of chest & throat which subsided; No difficutly breathing; phoned MD; transported by car to ER; sx progressed to vertigo & nausea;
VACCINE ADMINISTERED AFTER 31 DAY REFRIDGERATED BEYOND USE DATE BUT BEFORE THE 45 DAY EXCURSION DATE.
Patient became dizzy, flushed, and visibly diaphoretic. Patient stated he felt like he was going to pass out. Patient taken to a private observation room. Patient hypotensive. All other vital signs stable.  Juice offered and patient placed in recumbent position. Patient recovered within 15 minutes for a total observation period of 30  minutes. Patient walked out of clinic with mother in stable condition.
Initial report received from a health care professional (pharmacist) on 20 Aug 2010: On an unspecified date this patient received a 0.5 ml intramuscular dose of expired S-OIV FLUVIRIN (batch number 102149P1) that had an expiration date of 30 Apr 2010. No further information provided at the time of this report. Follow up report received from the health care professional on 14 Sep 2010: The patient was vaccinated with S-OIV FLUVIRIN, 0.5 ml intramuscularly in the left deltoid on 16 Aug 2010.
Patient received his vaccine through Hospital System. He presented to us at The Dermatology Clinic in April 9th, 2021 with a rash on his leg suspicious for a hypersensitivity reaction. He reported that he received the pfizer vaccine 2/19/21 and that the rash started approximately 4 days later. He went to a wound care vacility, then his PCP to have his legs examined but reported to us that none of their treatments helped. He did present to us with a hypersensitivity reaction, but we are unable to determine for sure if it was secondary to his vaccine or not. We felt it should be reported either way just in case. His rash has since completely resolved. I saw him on 9/1/21 and he had no remaining rash.
30 Minutes after vaccine given patient had local reaction 2cm x 1cm scattered flat redness. Patient was still in office and administered Benadryl and Orapred. Patient discharged alert, no SOB sign.
Approximately 48 hours after vaccination I began to experience nausea. Within a few hours I began to have stomach cramps of increasing frequency and intensity. Approximately 60 hours after the vaccination I began vomiting. This lasted about 6 hours. The stomach cramps continued and then an intense headache that included both a squeezing and pounding sensation was also experienced. It was difficult to eat anything besides dry crackers and water as any intake was met by more intense cramping. The stomach pains continued for approximately 72 hours and the headache for 48 hours. I was unable to work for 3 days during this time.
Raise hump at injection which was hot to touch and red; Raise hump at injection which was hot to touch and red; Aches; Raise hump at injection which was hot to touch and red; Fatigue; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 27Apr2021 at 10:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to cashews. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 12:00, the patient experienced fatigue, fever, chills, aches, and raised hump at injection which was hot to touch and red. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, fever, chills, aches and raise hump at injection which was hot to touch and red was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
COVID ARM - THE SITE OF THE SHOT IS RED, ITCHING, HOT AND PAINFUL
Starting about 12 hours after shot: Fever of 99.5 for about 48 hours, painfully achy joints for 24 hours, intermittent headache ,  breathlessness  and fatigue continuing.  I walk 4-6 miles, briskly 5  or 6 days out of 7 (briskly meaning 15-18 minutes per mile).   This morning could not walk 200 yards without being so out of breath I had to bend over my knees to catch it, as if I had sprinted a 400meter race.  And just feel tired.
ARM BECAME RED, SWOLLEN, AND TENDER/SORE. ABOUT 6 INCH IN DIAMETER RED SWOLLEN MARK.
Received Td vaccine, woke up that night crying, temp of 102, shaking- mom gave Motrin-then 10m later c/o neck hurting and not being able to move her legs-taken to ER-mom states given IV fluids, EKG, and labs normal, urine, neg.- follow up visit with pediatrician showed erythematous circular lesion on left deltoid. Otherwise unremarkable.
Information has been received from a physician concerning a 67 year old male with a hypertension and hypothyroidism and a history of multiple non-melanoma skin cancers, no known drugs allergies, who on 27-FEB-2009 was vaccinated with a dose of ZOSTAVAX (Merck) subcutaneously into the left arm. Concomitant therapy included SYNTHROID, verapamil, hydrochlorothiazide (manufacturer unknown), allopurinol, losartan potassium (MSD), aspirin and multi-vitamins (unspecified). On 02-MAR-2009 the patient developed dermatomal zoster like lesions after administration of ZOSTAVAX (Merck). The patient had approximately 15 lesions at the right T5 dermatome. Patient was experiencing pain. On 03-MAR-2009 a viral culture was performed. The patient sought medical attention through an office visit. At the time of this report the patient had not recovered. Follow up information received on 22-APR-2009 from the physician stated that a patient, with a zoster like reaction at the time of vaccination and a negative culture recovered 1 week later. No further information is available.
Burning of the corner of the mouth, extending to upper lip. No rash, very mild redness. This occurred every few days, then every week, then every few weeks, then every few months until by the end of the year the symptoms stopped completely.
Patient had previously received a dose of Moderna vaccine lot #008C21A on 05/08/2021
sight rash on the R arm and legs; reaction below the injection site: large rectangular red blooded area of two inches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (reaction below the injection site: large rectangular red blooded area of two inches) and RASH (sight rash on the R arm and legs) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for an unknown indication.     The patient's past medical history included No adverse event. Concomitant products included THYROID and ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (reaction below the injection site: large rectangular red blooded area of two inches) and RASH (sight rash on the R arm and legs). At the time of the report, INJECTION SITE ERYTHEMA (reaction below the injection site: large rectangular red blooded area of two inches) and RASH (sight rash on the R arm and legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Fever of 102 ax followed in 24 hrs by apparent sz (limpness, apnea, staring, tongue chewing); dx febrile seizure secondary to febrile response to MMR; t103.6, P160, R48;
Information has been received from a pharmacist concerning a 65 year old female who on 21-FEB-2009 was vaccinated with one dose of ZOSTAVAX (Oka/Merck) (Lot# not reported). Two days later, on 23-FEB-2009 the patient had a case of anaphylaxis. Now the patient recovered from anaphylaxis. It was reported that the patient sought unspecified medical attention. Additional information has been requested.
SOB, chest tightness, hives on body, face, mouth, eyes. Treated at clinic with 50mg BENADRYL IM and 600mg Ibuprofen PO.
Patient experienced nausea, dizziness and chills w/o fever 2-3 hours after vaccine and symptoms have continued to today.
36 hours after vaccine in left deltoid, large swelling and erythema rash noted on distal biceps near elbow joint with swelling of entire deltoid and biceps.
Flu Like Symptoms; Chills; injection site cold; Difficulty walking; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th April 2019, the patient received the 1st dose of Shingrix (intramuscular). On 24th April 2019, 2 hrs after receiving Shingrix, the patient experienced influenza-like symptoms, chills, feeling cold and walking difficulty. On an unknown date, the outcome of the influenza-like symptoms, chills, feeling cold and walking difficulty were recovering/resolving.   It was unknown if the reporter considered the influenza-like symptoms, chills, feeling cold and walking difficulty to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the right arm. About 2 to 3 hours post vaccination the patient experienced flu like symptoms, chills, cold to touch and difficulty walking. At the time of reporting, the patient was feeling better than day of vaccination. The reporter did not give consent to follow up. No further details were provided.
An acute episode of vomiting lasting 30 minutes. Vomited 5-6 times in that span.
Vial was stored in refrigerator on 17-Feb-2022, expired on 1-Apr-2022 and administered on 07-Apr-2022; 21 patients administered with expired vaccines/25 Patients Identifiers Update for Safety; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (21 patients administered with expired vaccines/25 Patients Identifiers Update for Safety) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 17-Feb-2022, expired on 1-Apr-2022 and administered on 07-Apr-2022) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (21 patients administered with expired vaccines/25 Patients Identifiers Update for Safety). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 17-Feb-2022, expired on 1-Apr-2022 and administered on 07-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (21 patients administered with expired vaccines/25 Patients Identifiers Update for Safety) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 17-Feb-2022, expired on 1-Apr-2022 and administered on 07-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Date the vial was initially stored in the refrigerator on  17-Feb-2022. The vial did not undergo any temperature excursions.  It was reported that no patients had come out with adverse events.  vials associated with storage excursion likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.  The treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 11-Apr-2022: Non Significant Follow up appended
Low blood pressure hypotension with a lot of sleep from 3/30/2021 to 3/31/2021. Arm pain going up to the head and back 3/29/2021 to 4/9/2021 Hives almost all over the body from 2/4/2021 to 3/4/2021. Burning in throat with pain 4 /? / 2021 to present. General malaise and sensitivity to allergies up to the present 4/16/2021 onset of urticaria controlled with Benadryl 4/16/2021 and 4/17/2021 fever.